Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Epilepsia ; 57(11): 1808-1816, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27762437

RESUMO

OBJECTIVE: To describe the clinical, neuropsychological, and psychopathologic features of a cohort of children with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy at time of recruitment and through the first month. The selected population will be followed for 2-5 years after enrollment to investigate the epilepsy course and identify early predictors of drug resistance. METHODS: In this observational, multicenter, nationwide study, children (age 1 month-12.9 years) with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy were consecutively enrolled in 15 Italian tertiary childhood epilepsy centers. Inclusion criteria were as follows: (1) diagnosis of symptomatic focal epilepsy due to acquired and developmental etiologies, and presumed symptomatic focal epilepsy; (2) age at diagnosis older than 1 month and <13 years; and (3) written informed consent. Children were subdivided into three groups: ≤3 years, >3 to 6 years, and >6 years. Clinical, electroencephalography (EEG), neuroimaging, and neuropsychological variables were identified for statistical analyses. RESULTS: Two hundred fifty-nine children were enrolled (116 female and 143 male). Median age: 4.4 years (range 1 month-12.9 years); 46.0% (n = 119) of children were younger than 3 years, 24% (61) from 3 to 6 years of age, and 30% (79) older than 6 years. Neurologic examination findings were normal in 71.8%. Brain magnetic resonance imaging (MRI) was abnormal in 59.9%. Children age ≤3 years experienced the highest seizure frequency in the first month after recruitment (p < 0.0001). Monotherapy in the first month was used in 67.2%. Cognitive tests at baseline revealed abnormal scores in 30%; behavioral problems were present in 21%. At multivariate analysis, higher chances to exhibit more than five seizures in the first month after epilepsy onset was confirmed for younger children and those with temporal lobe epilepsy. SIGNIFICANCE: In this prospective cohort study, an extensive characterization of epilepsy onset in children with symptomatic or presumed symptomatic focal epilepsies is reported in relation to the age group and the localization of the epileptogenic zone.


Assuntos
Encéfalo/diagnóstico por imagem , Transtornos Cognitivos/etiologia , Epilepsias Parciais/complicações , Adolescente , Distribuição por Idade , Criança , Pré-Escolar , Transtornos Cognitivos/diagnóstico , Estudos de Coortes , Eletroencefalografia , Epilepsias Parciais/diagnóstico por imagem , Feminino , Humanos , Lactente , Recém-Nascido , Imageamento por Ressonância Magnética , Masculino , Testes Neuropsicológicos , Estudos Prospectivos
2.
Pediatr Pulmonol ; 43(10): 1036-9, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18785257

RESUMO

We report the case of a 15-month-old male suffering from Late Onset Congenital Central Hypoventilation Syndrome and recto-sigmoid Hirschsprung's disease, an association that has not been reported thus far. Nevertheless, our patient showed a missense mutation of the PHOX2B gene already known in isolated late onset central hypoventilation, resulting in a substitution of the Ala140 residue with a Glu residue (p.A140E). The present association of LO-CHS and HSCR in a patient harboring a rare and atypical PHOX2B mutation allows to refine the mutational spectrum of this disease and suggests individualized ventilatory care along with specific surgical and oncological approaches.


Assuntos
Doença de Hirschsprung/genética , Proteínas de Homeodomínio/genética , Apneia do Sono Tipo Central/genética , Fatores de Transcrição/genética , Adolescente , Idade de Início , Humanos , Masculino , Mutação de Sentido Incorreto
3.
Am J Respir Crit Care Med ; 174(6): 706-9, 2006 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-16763219

RESUMO

Congenital central hypoventilation syndrome (CCHS) is a rare neurocristopathy characterized by absence of automatic control of respiration; decreased sensibility to hypoxia and hypercapnia, mainly during sleep; and autosomal dominant inheritance due to heterozygous polyalanine expansions and frameshift mutations in the PHOX2B gene. Because the CCHS phenotype could hide other neurologic diseases, the American Thoracic Society established that the initial evaluation of suspected CCHS should exclude neuroanatomic impairments as the structural basis of the reduced autonomic system function. In this work, we describe the clinical history of two unrelated patients with hypoventilation during sleep and harboring hypoplasia of the pons and a Chiari I malformation, respectively. In both patients, CCHS was diagnosed by detection of PHOX2B polyalanine expansion, suggesting that the American Thoracic Society diagnostic criteria may be too restrictive. Moreover, to exclude a putative role of PHOX2B in non-CCHS neurologic diseases, we have performed PHOX2B mutation screening in a group of individuals with Chiari I malformation, confirming the exclusive role of PHOX2B in the pathogenesis of CCHS.


Assuntos
Tronco Encefálico/anormalidades , DNA/análise , Proteínas de Homeodomínio/genética , Mutação , Apneia do Sono Tipo Central/congênito , Fatores de Transcrição/genética , Adulto , Pré-Escolar , Diagnóstico Diferencial , Feminino , Testes Genéticos/métodos , Genótipo , Humanos , Imageamento por Ressonância Magnética , Masculino , Proteínas do Tecido Nervoso/genética , Apneia do Sono Tipo Central/diagnóstico , Apneia do Sono Tipo Central/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA